Arkolith/Insider Trading/HILS/Form 4

Milby Randy

Chief Executive Officer, DirectorHillstream BioPharma Inc. (HILS) · full profile →Form 4 · filed Jan 20, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
30
15 non-derivative · 15 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2022Conversion(C)23K$3.20$74K2.2M
Jan 14, 2022Conversion(C)18K$3.20$57K2.4M
Jan 14, 2022Conversion(C)16K$3.20$51K2.3M
Jan 14, 2022Conversion(C)23K$3.20$74K2.2M
Jan 14, 2022Conversion(C)406$3.20$1K2.2M
Jan 14, 2022Conversion(C)7K$3.20$21K2.3M
Jan 14, 2022Conversion(C)15K$3.20$48K2.2M
Jan 14, 2022Conversion(C)16K$3.20$53K2.3M
Jan 14, 2022Conversion(C)22K$3.20$69K2.3M
Jan 14, 2022Conversion(C)13K$3.20$42K2.3M
Jan 14, 2022Conversion(C)25K$3.20$79K2.3M
Jan 14, 2022Conversion(C)20K$3.20$63K2.4M
Jan 14, 2022Conversion(C)22K$3.20$71K2.4M
Jan 14, 2022Conversion(C)24K$3.20$78K2.4M
Jan 14, 2022Conversion(C)17K$3.20$53K2.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-001677) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML